President Donald Trump is set to announce that all 50 U.S. states will join a Medicaid drug pricing program that offers “most favored nation” pricing for certain drugs covered under Medicaid, according to ABC News.
The plan is described as extending a pricing arrangement to states nationwide, aiming to standardize what Medicaid pays for specified medications. The Winnipeg Free Press similarly reports that Trump will announce that all 50 states are joining the model.
Across the two outlets, the core details are consistent: the announcement involves nationwide participation by states and focuses on most favored nation pricing for some Medicaid drugs. The reporting does not present differing substantive outcomes or figures in the provided excerpts, but both emphasize the scope of adoption—covering every state.
